Ibarani, Jenilyn .

HRN: 16-50-64  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2025
CEFUROXIME 500MG (TAB)
12/27/2025
01/02/2026
PO
500 Mg
BID
S/P NSVD With Inc Wbc
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines